双动脉和透导管替换:可行性和安全性
Flavius Alexandru Gherasie1, Cristian Alexandru Udroiu2
1"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Maedica
|June 2, 2023
概括
过导管大动脉置换 (TAVR) 是严重大动脉狭窄的安全选择,包括双大动脉 (BAV) 患者. 然而,BAV中的TAVR可能会增加对膜反和心脏起器植入的风险.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 透导管大动脉置换 (TAVR) 现在是严重的症状大动脉狭窄症 (AS) 的标准,扩展到低风险患者.
- 从历史上看,双主动脉 (BAV) 患者被排除在主要TAVR试验之外.
- 双管状AS是经过过导管植入的患者的常见发现.
更多相关视频
相关概念视频
Mitral Stenosis III: Medical Management
14
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
14
Aortic Regurgitation III: Medical Management
27
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
27


